GELESIS

Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of materials that are General Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Each Gelesis100 capsule contains thousands of hydrogel particles approximately the size of a grain of salt that expand to 100 times their dry weight. The pill is designed to act mechanically in the stomach and small intestine to increase satiety and decrease hunger, resulting in reduced caloric intake and weight loss. Gelesis was founded in 2006 in Boston, Massachusetts

#SimilarOrganizations #People #Financial #Website #More

GELESIS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Diabetes Health Care Medical Device

Founded:

2006-02-01

Address:

Boston, Massachusetts, United States

Country:

United States

Website Url:

http://www.gelesis.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

312.8 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Google Tag Manager WordPress Content Delivery Network Font Awesome

Similar Organizations

biomodex-logo

BIOMODEX

BIOMODEX is a medical technology company using 3D printing to create tissue-like anatomical twins for rehearsal of surgeries.

eicosis-logo

EicOsis

EicOsis Human Health is developing a first-in-class therapy of a once daily

icad-logo

iCAD

iCAD develops and delivers cancer detection and radiation therapy solutions, and services that enable clinicians to find and treat cancers.

retina-implant-logo

Retina Implant

Retina Implant is a biotech company which develops subretinal implants for partially sighted and blind patients.

Current Advisors List

not_available_image

Ken Fujioka Advisor @ Gelesis
Advisor

not_available_image

Meghan FitzGerald Board Member @ Gelesis
Board_member

elon-boms_image

Elon Boms Director & Board Member @ Gelesis
Board_member
2012-06-01

not_available_image

Allan Geliebter Clinical Advisor @ Gelesis
Advisor

not_available_image

Lee M. Kaplan Clinical Advisor @ Gelesis
Advisor

not_available_image

Louis Aronne Advisor @ Gelesis
Advisor

john-lamattina_image

John LaMattina Chairman @ Gelesis
Board_member

not_available_image

Louis Aronne Advisor @ Gelesis
Advisor

Current Employees Featured

torsten-winkler_image

Torsten Winkler
Torsten Winkler Investor @ Gelesis
Investor
2019-12-01

not_available_image

Hassan M. Heshmati
Hassan M. Heshmati Executive Vice President, Endocrinology and Metabolism @ Gelesis
Executive Vice President, Endocrinology and Metabolism
2009-10-01

paul-fonteyne_image

Paul Fonteyne
Paul Fonteyne Independent Director @ Gelesis
Independent Director
2018-01-01

elaine-chiquette_image

Elaine Chiquette
Elaine Chiquette Chief Scientific Officer @ Gelesis
Chief Scientific Officer
2018-09-01

david-pass_image

David Pass
David Pass Chief Commercial & Operating Officer @ Gelesis
Chief Commercial & Operating Officer
2016-09-01

yishai-zohar_image

Yishai Zohar
Yishai Zohar CEO and Founder @ Gelesis
CEO and Founder
2006-05-01

harry-leider_image

Harry Leider
Harry Leider Chief Medical Officer @ Gelesis
Chief Medical Officer
2018-01-01

Founder

not_available_image

Eyal S. Ron

yishai-zohar_image

Yishai Zohar

Stock Details

Company's stock symbol is NYSE:GLS

Investors List

kennedy-lewis-investment-management_image

Official Site Inspections

http://www.gelesis.com Semrush global rank: 1.38 M Semrush visits lastest month: 20.81 K

Host Informations
Whois Informations

Loading ...